Beth C. Seidenberg - Mar 1, 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Mar 1, 2023
Transactions value $
$170,047
Form type
4
Date filed
3/3/2023, 03:07 PM
Previous filing
Feb 27, 2023
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $725 +100 +0.01% $7.25 1.67M Mar 1, 2023 See footnote F1, F2
transaction VERA Class A Common Stock Purchase $169K +23.4K +1.4% $7.24 1.69M Mar 2, 2023 See footnote F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased as follows: 97 shares by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 3 shares by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
F2 Consists of 1,609,893 shares of Class A Common Stock held by KPCB XVI and 55,109 shares of Class A Common Stock held by XVI Founders.
F3 The shares were purchased as follows: 22,604 shares by KPCB XVI and 774 shares by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
F4 Represents weighted average purchase price. The shares were purchased at prices ranging from $7.22 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F5 Consists of 1,632,497 shares of Class A Common Stock held by KPCB XVI and 55,883 shares of Class A Common Stock held by XVI Founders.